ClinConnect ClinConnect Logo
Search / Trial NCT05911893

the Effect of High Caloric Oral Nutritional Supplements on Growth and Development of Malnourished Children

Launched by CHILDREN'S HOSPITAL OF CHONGQING MEDICAL UNIVERSITY · Jun 16, 2023

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Oral Nutritional Supplements Physique Growth Neuropsychological Development

ClinConnect Summary

This clinical trial is looking at how high-calorie oral nutritional supplements can help malnourished children aged 1 to 3 years. The goal is to see if these supplements can improve their growth, weight, and overall development, including their gut health and immune function. Children in the study will receive daily nutritional education and either the high-calorie supplements or just dietary guidance without the supplements. This research could help create better care strategies for malnourished children in China.

To participate, children must be between 1 and 3 years old and show signs of malnutrition, such as being underweight or having a low body mass index (BMI). Their guardians must also agree to join the study. Unfortunately, children with certain health conditions, like severe diseases or specific genetic disorders affecting growth, cannot take part. If eligible, participants will receive support and monitoring throughout the trial to ensure their safety and well-being.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Aged 1-3 years
  • BMI for Age Z-score\<-2
  • Height-for-age z score\<-2
  • Total daily energy intake\<75% of recommended nutrient intake
  • The child's guardian is willing to participate in this study and sign an informed consent form.
  • Exclusion Criteria:
  • Chronic or severe infectious disease (e.g., chronic hepatitis, HIV or tuberculosis infection)
  • Certain congenital or genetic diseases affecting physical growth and development (congenital heart disease, Down's syndrome, infantile anorexia nervosa, etc.), malignancies and use of drugs (diuretics, appetite stimulants, steroids and growth hormones, etc.)
  • Severe gastrointestinal disorders (e.g., celiac disease, short bowel syndrome, inflammatory bowel disease, etc.)
  • Acute and chronic respiratory/digestive tract infections within 2 weeks prior to enrollment
  • Allergy or contraindication to any of the ingredients in the high-energy total nutrition formula used in this study
  • Have used high-energy enteral nutrition preparations for the last 3 months

About Children's Hospital Of Chongqing Medical University

The Children's Hospital of Chongqing Medical University is a leading pediatric healthcare institution in China, dedicated to advancing child health through innovative clinical research and comprehensive medical care. As a prominent clinical trial sponsor, the hospital focuses on developing and evaluating new treatments and interventions for a wide range of pediatric conditions. With a commitment to improving health outcomes for children, the institution leverages its expertise in pediatric medicine, state-of-the-art facilities, and collaboration with academic and research partners to conduct rigorous clinical trials that adhere to the highest ethical and scientific standards.

Locations

Nanjing, Jiangsu, China

Nanchang, Jiangxi, China

Changsha, Hunan, China

Chongqing, Chongqing, China

Hefei, Anhui, China

Beijing, Beijing, China

Guangzhou, Guangdong, China

Guiyang, Guizhou, China

Baoji, Shanxi, China

Xianyang, Shanxi, China

Chengdu, Sichuan, China

Kunming, Yunnan, China

Patients applied

0 patients applied

Trial Officials

Li Chen, doctor

Study Director

Children's Hospital of Chongqing Medical University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported